New Zealand markets closed

Cocrystal Pharma, Inc. (COCP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.5500+0.0600 (+2.41%)
At close: 04:00PM EDT
2.5700 +0.02 (+0.78%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 25.94M
Enterprise value 5.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.15
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.66

Trading information

Stock price history

Beta (5Y monthly) 1.39
52-week change 36.25%
S&P500 52-week change 325.87%
52-week high 33.2900
52-week low 31.3300
50-day moving average 31.9432
200-day moving average 31.7701

Share statistics

Avg vol (3-month) 330.48k
Avg vol (10-day) 351.47k
Shares outstanding 510.17M
Implied shares outstanding 610.17M
Float 87.1M
% held by insiders 130.03%
% held by institutions 17.09%
Shares short (15 May 2024) 46.28k
Short ratio (15 May 2024) 40.32
Short % of float (15 May 2024) 40.08%
Short % of shares outstanding (15 May 2024) 40.06%
Shares short (prior month 15 Apr 2024) 41.49k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 324 Jan 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 311 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-39.23%
Return on equity (ttm)-58.52%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.03M
Net income avi to common (ttm)-16.75M
Diluted EPS (ttm)-1.6200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.84M
Total cash per share (mrq)2.15
Total debt (mrq)1.82M
Total debt/equity (mrq)8.07%
Current ratio (mrq)10.30
Book value per share (mrq)2.22

Cash flow statement

Operating cash flow (ttm)-16.06M
Levered free cash flow (ttm)-12.03M